Uso de biológicos para asma grave en otras indicaciones fuera de ficha técnica (off label)

Marcos, C; Pinedo Sierra, C; Cisneros Serrano, C.
Rev. patol. respir ; 23(supl.1): S12-S21, feb. 2020. graf, ilus
Artículo en Español | IBECS (España) | ID: ibc-188030

Documentos relacionados

  1. Biologics for oral corticosteroid-dependent asthma.
  2. Treatment of severe, uncontrolled eosinophilic asthma: Where we are heading.
  3. [Bronchial asthma: characteristics of modern diagnostics].
  4. Outcomes of rapid corticosteroid tapering in acute eosinophilic pneumonia patients with initial eosinophilia.
  5. Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study.
  6. Monoclonal antibodies in idiopathic chronic eosinophilic pneumonia: a scoping review.
  7. [A CASE OF EOSINOPHILIC BRONCHIOLITIS COMPLICATED WITH BRONCHIAL ASTHMA AND CHRONIC EOSINOPHILIC PNEUMONIA].
  8. [Eosinophilic pneumonia, how to differentiate: classification and diagnostic approach].
  9. New Therapeutic Approach to Treat Allergic Rhinitis & Bronchial Asthma, Considering These Two as One United Airway Disease.
  10. Clinical outcomes in patients with acute eosinophilic pneumonia not treated with corticosteroids.